Pfizer Vaccines US Medical Affairs hosting Informational sessions on COMIRNATY®.
On September 2nd, 2021
The Pfizer Vaccines US Medical Affairs team will be hosting “Medical Updates: Pfizer-BioNTech COVID-19 Vaccine, also known as COMIRNATY® (COVID-19 Vaccine, mRNA),” on Tuesdays, at 5pm ET and Thursday’s at 12pm ET for the remainder of 2021.
These sessions will be continuously updated to reflect new information and changes that evolve. Such updates will be identified at the start of each session and further explained during each presentation. I thought these might be of interest to you and your membership.
The topics for the current sessions, subject to change, include:
· FDA approval in individuals 16 years of age and older
· Third dose authorization for immunocompromised persons
· Packaging update
· Shelf-life extension and temperature range
· Storage, handling & administration.
Please click on the links below to join the sessions at the designated times over the next several weeks:
Date & Time Password Attendee link – September 7 – 5 PM ET mMmjfet3d37 Attendee link – September 9 – 12 PM ET vRpX6NtUU78 Attendee link – September 14 – 5 PM ET TYzDaBgA443 Attendee link – September 16 – 12 PM ET QbzXr3vJX49 Attendee link – September 21 – 5 PM ET nkGCMMg4c36 Attendee link – September 23 – 12 PM ET RvUiSSF35u6 Attendee link – September 28 – 5 PM ET mDupB8pvQ76 Attendee link – September 30 – 12 PM ET 5DbFhJpFg43
Before administration of the vaccine, please see full Prescribing Information (16+ years of age) and EUA Fact Sheet for Vaccination Providers (12+ years of age).
The Pfizer Vaccines US Medical Affairs team will be hosting “Medical Updates: Pfizer-BioNTech COVID-19 Vaccine, also known as COMIRNATY® (COVID-19 Vaccine, mRNA),” on Tuesdays, at 5pm ET and Thursday’s at 12pm ET for the remainder of 2021.
These sessions will be continuously updated to reflect new information and changes that evolve. Such updates will be identified at the start of each session and further explained during each presentation. I thought these might be of interest to you and your membership.
The topics for the current sessions, subject to change, include:
· FDA approval in individuals 16 years of age and older
· Third dose authorization for immunocompromised persons
· Packaging update
· Shelf-life extension and temperature range
· Storage, handling & administration.
Please click on the links below to join the sessions at the designated times over the next several weeks:
| Date & Time | Password |
| Attendee link – September 7 – 5 PM ET | mMmjfet3d37 |
| Attendee link – September 9 – 12 PM ET | vRpX6NtUU78 |
| Attendee link – September 14 – 5 PM ET | TYzDaBgA443 |
| Attendee link – September 16 – 12 PM ET | QbzXr3vJX49 |
| Attendee link – September 21 – 5 PM ET | nkGCMMg4c36 |
| Attendee link – September 23 – 12 PM ET | RvUiSSF35u6 |
| Attendee link – September 28 – 5 PM ET | mDupB8pvQ76 |
| Attendee link – September 30 – 12 PM ET | 5DbFhJpFg43 |
Before administration of the vaccine, please see full Prescribing Information (16+ years of age) and EUA Fact Sheet for Vaccination Providers (12+ years of age).
No comments have been posted yet.